<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/8757" />
  <subtitle />
  <id>http://localhost:8080/xmlui/handle/123456789/8757</id>
  <updated>2026-04-15T16:10:10Z</updated>
  <dc:date>2026-04-15T16:10:10Z</dc:date>
  <entry>
    <title>Giant Pyonephrosis Due to Calculus of Ureter: A Case Report</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/8771" />
    <author>
      <name>Andrian Singgih, Nicholas</name>
    </author>
    <author>
      <name>Kristian Lionardi, Stevan</name>
    </author>
    <author>
      <name>Mintardi, Mintardi</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/8771</id>
    <updated>2024-12-06T02:56:13Z</updated>
    <published>2023-12-31T00:00:00Z</published>
    <summary type="text">Title: Giant Pyonephrosis Due to Calculus of Ureter: A Case Report
Authors: Andrian Singgih, Nicholas; Kristian Lionardi, Stevan; Mintardi, Mintardi
Abstract: Abstract&#xD;
Giant pyonephrosis (GP) is a rare and severe form of pyonephrosis characterized by a massive enlargement&#xD;
of the affected kidney due to the accumulation of infected fluid. This study presents case of a 51-year-old&#xD;
male patient with giant pyonephrosis who underwent nephrectomy as treatment. The clinical manifestations&#xD;
of giant pyonephrosis are nonspecific, necessitating the use of imaging and laboratory techniques to aid in&#xD;
diagnosis. Nephrectomy is the preferred treatment option for these patients. One week after nephrectomy, the&#xD;
laboratory results showed improvements. Making the right treatment decision is challenging in this particular&#xD;
case.&#xD;
Keywords: Abdominal mass, case report, giant pyonephrosis, ureteropelvic junction obstruction</summary>
    <dc:date>2023-12-31T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Continuous Ambulatory Peritoneal Dialysis Cost-Effectiveness  in National Health Insurance Era of Indonesia</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/8770" />
    <author>
      <name>Tjahjodjati, Tjahjodjati</name>
    </author>
    <author>
      <name>Kuddah, Yasser</name>
    </author>
    <author>
      <name>Wijayanti, Zola</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/8770</id>
    <updated>2024-12-06T02:54:11Z</updated>
    <published>2023-12-31T00:00:00Z</published>
    <summary type="text">Title: Continuous Ambulatory Peritoneal Dialysis Cost-Effectiveness  in National Health Insurance Era of Indonesia
Authors: Tjahjodjati, Tjahjodjati; Kuddah, Yasser; Wijayanti, Zola
Abstract: Abstract&#xD;
Essential treatments for patients with end-stage renal disease include Renal Replacement Therapy (RRT)&#xD;
consisting of hemodialysis, peritoneal dialysis, and kidney transplantation. In 2014, dialysis coverage in&#xD;
Indonesia was more than 1.5 trillion, making it the second highest expense in the National Health Insurance&#xD;
(BPJS) expenses. This study compared the cost-effectiveness between Continuous Ambulatory Peritoneal&#xD;
Dialysis (CAPD) and Hemodialysis (HD) in patients treated in Dr. Hasan Sadikin General Hospital. Data were&#xD;
collected from the Urology Department from 2014 to 2017. This was a retrospective observational study on&#xD;
3 groups of patients: patients with effective CAPD each year as the first group; patients who had experienced&#xD;
repair of CAPD and continued to use it as the second group; and patients who discontinued CAPD due to&#xD;
complications and returned to hemodialysis as the third group. Each group expense was calculated with&#xD;
standard cost insurance for one year in the hospital. The expense was then be compared to the expense&#xD;
of hemodialysis for one year. A total of 89 patients in the CAPD program from 2014–2017 were treated at&#xD;
the department. When compared to HD, the first, second, and third group of CAPD patients experienced a&#xD;
cost reduction of IDR 23.227.857/person, IDR 18.127.857/person, and IDR 1.661.972.000, respectively.&#xD;
Total savings from the CAPD program in the hospital was IDR 1.661.972.000 from 2014. It is then concluded&#xD;
that CAPD could reduce the burden of government insurance in a cost-effective manner and is considered a&#xD;
treatment of choice in the National Health Insurance Era.&#xD;
Keywords: Chronic kidney disease, continuous ambulatory peritoneal dialysis, cost-effectiveness analysis,&#xD;
 hemodialysis national health insurance</summary>
    <dc:date>2023-12-31T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Validity Test For C-Reactive Protein and Ferritin Level in Moderate and Severe Covid-19 Patients</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/8769" />
    <author>
      <name>Putriasni Kurnia, Chyntia</name>
    </author>
    <author>
      <name>Wasilah Leni Lismayanti, Fajar</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/8769</id>
    <updated>2024-12-06T02:52:10Z</updated>
    <published>2023-12-31T00:00:00Z</published>
    <summary type="text">Title: Validity Test For C-Reactive Protein and Ferritin Level in Moderate and Severe Covid-19 Patients
Authors: Putriasni Kurnia, Chyntia; Wasilah Leni Lismayanti, Fajar
Abstract: Abstract&#xD;
Mild, moderate, severe, and critical COVID-19 are associated with hyperinflammation. The CRP and ferritin are&#xD;
acute phase proteins that marks incidence of inflammation and used as the paramaters of hyperinflammation.&#xD;
This study aimed to determine the validity of CRP and ferritin level examination in moderate and severe&#xD;
COVID-19 since the time of admission. This was a cross-sectional analytical retrospective study with on&#xD;
moderate and severe COVID-19 patients admitted to Dr. Hasan Sadikin General Hospital Bandung, Indonesia,&#xD;
during the period of March 2020 to December 2020. The CRP and ferritin levels were obtained since the&#xD;
beginning of admission to the fourth day since admission on patients without any history of anemia. Subjects&#xD;
in this study were divided into moderate and severe COVID-19 groups based on the 3rd edition of COVID-19&#xD;
Prevention and Control Guideline issued by the Ministry of Health Republic of Indonesia. Each group consisted&#xD;
of 30 subjects. The cut-off value was 7.65 mg/dL (AUC 0.698) for CRP and 963.1 mcg/L (AUC 0.938) for ferritin.&#xD;
The validity of ferritin vs CRP were reflected respectively as follows: 93.3% vs 76.7% sensitivity; 80.0% vs&#xD;
63.3% specificity; 82.4% vs 67.6% PPV; and 92.3% vs 73.1% NPV. The validity of ferritin was proven to be&#xD;
superior as it significantly increases since day one, persisted longer and reaches its peak on the16th day.&#xD;
Meanwhile, CRP increases within 6-8 hours and reaches its peak within 48 hours after inflammation, then&#xD;
declines soon afterwards.&#xD;
Keywords:</summary>
    <dc:date>2023-12-31T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Accuracy of Kampala Trauma Score as a Predictor in Assessing the Prognostic Value of Multiple Trauma</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/8768" />
    <author>
      <name>Usman, Nurhayat</name>
    </author>
    <author>
      <name>Ruchimat, Tommy</name>
    </author>
    <author>
      <name>Rahmawan, Andhika</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/8768</id>
    <updated>2024-12-06T02:51:20Z</updated>
    <published>2023-12-31T00:00:00Z</published>
    <summary type="text">Title: Accuracy of Kampala Trauma Score as a Predictor in Assessing the Prognostic Value of Multiple Trauma
Authors: Usman, Nurhayat; Ruchimat, Tommy; Rahmawan, Andhika
Abstract: Abstract&#xD;
Determining a trauma scoring system appropriate for certain conditions will help in predicting mortality and&#xD;
morbidity, and can determine the need for treatment in patients. Kampala Trauma Score (KTS) is a trauma&#xD;
scoring system that uses a decent number of assessment variables and can be used in all general groups. This&#xD;
study was a retrospective prognostic test conducted in Dr. Hasan Sadikin Hospital Bandung, Indonesia, from&#xD;
December 2021 to July 2022. Data obtained was processed using Microsoft Excel and SPSS spreadsheets. The&#xD;
respondents were 66 people with multiple trauma. Results showed that this study was dominated by patients&#xD;
with blunt trauma (n=63, 95.45%). The mean KTS score in this study was 13.08±1.03. In 49 (74.24%) patients&#xD;
who survived, the mean KTS score was 13.41±0.89 and in 17 (25.76%) patients who died, the mean KTS score&#xD;
was 12.12±0.79. The greatest mortality accuracy was at the cutoff point of the KTS score &gt;12 (81.82% accuracy;&#xD;
70.59% sensitivity; 85.71% specificity). The accuracy value of the KTS score is in line with the ROC where the&#xD;
optimal KTS score is &gt;12 (85.77%). In conclusion, the Kampala trauma score can be used as a predictor in&#xD;
assessing the prognostic value of multiple trauma patients with the obtained cut-point value as it has high&#xD;
accuracy, sensitivity, and specificity values.&#xD;
Keywords: Accuracy, KTS, multiple traumas, trauma scoring</summary>
    <dc:date>2023-12-31T00:00:00Z</dc:date>
  </entry>
</feed>

